相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela
Omaira Da Mata-Jardin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis
Mohammad Javad Nasiri et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Champa N. Ratnatunga et al.
FRONTIERS IN IMMUNOLOGY (2020)
In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex
Aristine Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Clinical Outcomes of Clofazimine Use for Rapidly Growing Mycobacterial Infections
George B. Carey et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
In vitro activity of aminoglycosides, clofazimine, D-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates
Chen-Cheng Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China
Jingjing Luo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis
Matthew Schwartz et al.
MICROBIAL DRUG RESISTANCE (2018)
Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study
Maroun Sfeir et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics
Yaojie Shen et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
Moloko C. Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria
Guilian Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria
Mohammad J. Nasiri et al.
FRONTIERS IN MICROBIOLOGY (2017)
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection
Stacey L. Martiniano et al.
CHEST (2017)
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
Julie Jarand et al.
CHEST (2016)
The antimicrobial susceptibility of non-tuberculous mycobacteria
S. Cowman et al.
JOURNAL OF INFECTION (2016)
Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
Rosemary V. Swanson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Treatment of Slowly Growing Mycobacteria
Julie V. Philley et al.
CLINICS IN CHEST MEDICINE (2015)
Nontuberculous Mycobacteria Skin and Soft Tissue Infections
Tania M. Gonzalez-Santiago et al.
DERMATOLOGIC CLINICS (2015)
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea
Song Yee Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
Hui Pang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
S. Singh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Update on the Epidemiology of Pulmonary Nontuberculous Mycobacterial Infections Preface
Brian A. Kendall et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Ecology of Nontuberculous Mycobacteria-Where Do Human Infections Come from? Preface
Joseph O. Falkinham
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
Jakko van Ingen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clofazimine: current status and future prospects
Moloko C. Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Gwan-Han Shen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Infections due to rapidly growing mycobacteria
Mary A. De Groote et al.
CLINICAL INFECTIOUS DISEASES (2006)
Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements
D van Soolingen
JOURNAL OF INTERNAL MEDICINE (2001)
分享论文
